THE ROLE OF PREDICTORS IN THE FORMATION OF THROMBOSIS IN ATRIAL FIBRILLATION (REVIEW ARTICLE)

Authors

  • BOLTAYEV Kamol Jumaevich
  • RIZAEVA Malika Jamolovna

Keywords:

atrial fibrillation, arrhythmia, coronary heart disease, remodeling, predictors.

Abstract

Atrial fibrillation (AF) is one of the unfavorable diseases of cardiology, because five times increases the risk of thromboembolic complications (TEC). AF is associated with a number of complications, such as cardioembolic variant of ischemic stroke (IS), worsens the quality of life, reduces exercise tolerance and increases the risk of death rate. A significant contribution to the formation of the pathogenesis of cardiac arrhythmias is played by factors associated with remodeling of the heart chambers and intracardiac hemodynamics.

References

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612.

Sohara H., Amitani S., Kurose M., Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation. Journal of the American College of Cardiology. 1997; 29(1): 106-12.

Chatterjee S, Bavishi C, Sardar P, et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am J Cardiol. 2014;114(7):1049-52. doi:10.1016/j. amjcard.2014.07.015

Zaigraev I.A., Yavelov I.S. Thrombosis of the left atrium and/or its auricle in non-valvular atrial fibrillation: the frequency of detection and clinical risk factors. Atherothrombosis. 2019;(2):68-79. https://doi.org/10.21518/2307-1109-2019-2-68-79 (in Russ)

Kornelyuk I.V., Persianskikh Yu.A., Rabtsevich V.A., & Kornelyuk O.M. (2015). The choice of anticoagulant preparation for cardioversion in patients with persistent atrial fibrillation, taking into account echocardiographic predictors of left auricle thrombosis. Medical News, (1 (244)), 37-40 (in Russ)

The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation //Ann. Intern. Med. – 1998. – Vol.128. – P.639–647

Khorkova N. Yu., Gizatullina T. P., Belokurova A.V., Gorbatenko E. A., & Yaroslavskaya E. I. (2021). Thromboembolic risk factors and predictors of left auricle thrombosis in patients of the far north with non-valvular atrial fibrillation. Russian Journal of Cardiology, (10), 100-106. (in Russ)

Hasnulin VI, Voevoda MI, Hasnulin PV, et al. Modern Approach to Arterial Hypertension in the Circumpolar and Arctic Regions. Literature Review. Ekologiya cheloveka [Human Ecology]. 2016;3:43-51.

Shurkevich NP, Vetoshkin AS, Gapon LI, et al. Chronostructure of blood pressure in shiftworkers in the Arctic polar region. “Arterial Hypertension”. 2015;21(5):500-13

Shenasa M, Shenasa H, El-Sherif N. Left ventricular hypertrophy and arrhythmogenesis. Card Electrophysiol Clin. 2015;7(2):207-20. doi:10.1016/j.ccep.2015.03.017

Zapesochnaya IL, Avtandilov AG. Five-year dynamics of circadian blood pressure profile in Far North workers with arterial hypertension. Russ J Cardiol. 2013;(6):48-53.

Boyd AC, McKay T, Nasibi S, et al. Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2013;14(3):269- 75. doi:10.1093/ehjci/jes153.

Hong-ling Yang, Yong-Ping Lin, Yan Long, Qing-ling Ma, Cheng Zhou. Predicting cardioembolic stroke with the B-type natriuretic peptide test: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2014;23(7):1882—1889. doi: 10.1016/j.jstrokecerebrovasdis.2014.02.014.

Pant R., Patel M., Garcia-Sayan E., Wassouf M., D’Silva O., Kehoe R.F., Doukky R. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. Cardiovasc Ultrasound. 2015;14:4. doi: 10.1186/s12947-016-0047-6

Kawabata M., Goya M., Sasaki T., Maeda S., Shirai Y., Yoshitake T. et al. Left atrial appendage thrombi formation in Japanese non-valvular atrial fibrillation patients during anticoagulation therapy – Warfarin vs. Direct Oral Anticoagulants. Circ J. 2017;81(5):645– 651. doi: 10.1253/circj.CJ-16-1089

Ochiumi Y., Kagawa E., Kato M., Sasaki S., Nakano Y., Itakura K. et al. Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation. J Arrhythm. 2015;31:307–312. doi: 10.1016/j.joa.2015.04.002.

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(4):412. doi: 10.1093/ehjci/jew041.

Mancia G., Fagard R., Narkiewicz K., Redán J., Zanchetti A., Böhm M. et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925–1238. doi: 10.1097/ HJH.0b013e328364ca4c.

Rizaeva, M. Z. (2022). The clinical course of atrial fibrillation in patients with coronary heart disease. European journal of molecular medicine, 2(1).

Boltaev, K. J., & Rizaeva, M. J. (2023). The risk of thromboembolism in atrial fibrillation (review article).Central Asian Journal of Medical and Natural Science, 4(3), 451-454. (in Russ)

Sh, A. N., & Rizaeva, M. J. (2023). Problems of hemostasis in patients with persistent atrial fibrillation on the background of coronary heart disease. Eurasian Research Bulletin, 21, 1-6.

Статья поступила в редакцию 07.03.2024; одобрена после рецензирования 25.04.2024; принята к публикации 26.04.2024.

The article was submitted 07.03.2024; approved after reviewing 25.04.2024; accepted for publication 26.04.2024

Сведения об авторах:

Болтаев Камол Жумаевич, Д.м.н., доцент, заведующий кафедрой «Гематологии и клинической лабораторной диагностики» Бухарского государственного медицинского факультета, boltayevkamol61@gmail.com ,+998 91 446 12 20 https://orcid.org/0000-0002-2074-984X

Ризаева Малика Жамоловна, ассистент кафедры «Анестезиология и реаниматология, детская анестезиология и реаниматология» Бухарского государственного медицинского института malikarizaev1990@gmail.com +998914001230 https://orcid.org/0009-0008-6649-4708

Источники финансирования: Работа не имела специального финансирования.

Конфликт интересов: Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.

Вклад авторов:

Болтаев К.Ж. — идеологическая концепция работы, написание текста; редактирование статьи;

Ризаева М.Ж. — сбор и анализ источников литературы, написание текста.

Information about authors:

Boltaev Kamol Jumaevich, Doctor of Medical Sciences, Associate Professor, Head of the Department of Hematology and Clinical Laboratory Diagnostics, Bukhara State Medical Faculty, boltayevkamol61@gmail.com ,+998 91 446 12 20 https://orcid.org/0000-0002-2074-984X

Rizaeva Malika Jamolovna, assistant at the Department of Anesthesiology and Reanimatology, Pediatric Anesthesiology and Resuscitation, Bukhara State Medical Institute malikarizaev1990@gmail.com +998914001230 https://orcid.org/0009-0008-6649-4708

Sources of funding: The work did not have special funding.

Conflict of interest: The authors declare that there are no obvious or potential conflicts of interest related to the publication of this article.

Authors' contributions:

Boltaev K.J. — ideological concept of the work, writing the text; article editing;

Rizaeva M.J. — collection and analysis of literature sources, writing text.

Downloads

Published

2024-06-02